The efficacy of ICIs between viral‐ and non‐viral‐related HCC significantly differ between viral‐ and non‐viral‐related HCC, while the liver etiology was not associated with the outcome of TKI/anti‐VEGF therapies.6 This evidence concerns the gene VEGFA and hepatocellular carcinoma.